We collected information about Apellis Pharmaceuticals Hours for you. Follow the liks to find out everything about Apellis Pharmaceuticals Hours.
Apellis is a global biopharmaceutical company that develops life-changing therapies. By pioneering targeted C3 therapies, we aim to treat diseases that are driven by excessive activation of the complement cascade, including those within hematology, ophthalmology, and nephrology.
https://apellis.com/contact-us/
Contact Us | Apellis. Call Us. (617) 977-5700 Main Office. (833) 866-3346 (833-TO-MEDINFO) Medical Information Call Center. Addresses. Main Office. 100 5th Avenue. Waltham, MA 02451, USA. Watertown, MA.
https://stockhouse.com/news/press-releases/2021/11/29/apellis-pharmaceuticals-to-present-at-the-4th-annual-evercore-isi-healthconx
Apellis Pharmaceuticals to Present at the 4th Annual Evercore ISI HealthCONx Conference APLS | 13 hours ago WALTHAM, Mass., Nov. 29, 2021 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals , Inc. (Nasdaq: APLS), a global biopharmaceutical company and leader in complement, today announced that the company will present at the 4th Annual Evercore ISI ...
https://www.nasdaq.com/market-activity/stocks/apls/after-hours
Apellis Pharmaceuticals, Inc. Common Stock (APLS) After-Hours Stock Quotes - Nasdaq offers after-hours quotes and extended trading activity data for US and global markets.
https://www.benzinga.com/analyst-ratings/21/11/24334615/analyst-ratings-for-apellis-pharmaceuticals
In the last 3 months, 8 analysts have offered 12-month price targets for Apellis Pharmaceuticals. The company has an average price target of $61.25 with a …
https://www.marketwatch.com/investing/stock/APLS
Apellis Pharmaceuticals started at buy with $40 stock price target at Stifel Nicolaus Sep. 1, 2020 at 7:34 a.m. ET by Tomi Kilgore Shares of Apellis rise on clinical data for rare blood disease drug
https://markets.businessinsider.com/news/stocks/analyst-ratings-for-apellis-pharmaceuticals-1031009472
In the last 3 months, 8 analysts have offered 12-month price targets for Apellis Pharmaceuticals. The company has an average price target of $61.25 with a …
https://www.barrons.com/market-data/stocks/apls
Complete Apellis Pharmaceuticals Inc. stock information by Barron's. View real-time APLS stock price and news, along with industry-best analysis. ... After Hours Vol. 205.55K. Price at close $38 ...
https://www.cnbc.com/quotes/APLS
Apellis Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company that is focused on developing novel therapeutic compounds to treat disease through the inhibition of the complement system.
https://www.marketwatch.com/story/apellis-pharmaceuticals-to-resubmit-nda-for-intravitreal-pegcetacoplan-271636720706
Apellis Pharmaceuticals Inc. said it received formal, written feedback from the U.S. Food and Drug Administration that further reinforces its plans to submit a New Drug Application for ...
Searching for Apellis Pharmaceuticals Hours?
You can just click the links above. The info is collected for you.
